CCM
SKBI

Corsair Capital Management’s SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) SKBI Stock Holding History

Corsair Capital Management’s Portfolio SKBI Stock Details SKBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-61,258
Closed -$358K – 118
2013
Q3 		$358K Sell
61,258
-179,536
-75% -$444K 0.05% 100
2013
Q2 		$308K Buy
+240,794
New +$341K 0.04% 95

Other funds holding SKBI

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Corsair Capital Management's SKBI Position: Q4 2013 in Review

Corsair Capital Management sold out of SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) (SKBI) in Q4 2013, closing a stake of 61,258 shares — an estimated $358K sold.

Corsair Capital Management first reported a position in SKBI in Q2 2013 and held it in 2 quarters. The position peaked at $358K in Q3 2013. 6 funds tracked by Wall St. Rank hold SKBI as of Q4 2013.

  • Corsair Capital Management reported no remaining SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position as of Q4 2013 after selling out during the quarter.
  • Corsair Capital Management sold 61,258 SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) shares in Q4 2013, an estimated $358K.
  • Corsair Capital Management first reported a position in SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) in Q2 2013 and held it in 2 quarters.
  • Corsair Capital Management's SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) position peaked at $358K in Q3 2013.
  • 6 funds tracked by Wall St. Rank held SKYSTAR BIO-PHARMACEUTICAL CO COM PAR $.001 (NV) as of Q4 2013.

Based on Corsair Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.